Biotinidase deficiency masquerading as multiple sclerosis?

4. Tanaka M and Tanaka K. Dose reduction therapy of fingolimod for Japanese patients with multiple sclerosis: 24-month experience. Clin Exp Neuroimmunol 2014; 5: 383–384. Masami Tanaka1,2,3 , Masako Kinoshita4 and Keiko Tanaka5 1Kyoto MS Center, Kyoto Min-Iren Chuo Hospital, Kyoto, Japan 2Department of Neurology, Kaikoukai Josai Hospital, Nagoya, Japan 3Department of Neurology, School of Medicine, Fujita Health University, Toyoake, Japan 4Department of Neurology, Utano National Hospital, Kyoto, Japan 5Department of Cellular Neurobiology, Brain Research Institute, Niigata University, Niigata, Japan

[1]  B. Wolf.  Successful outcomes of older adolescents and adults with profound biotinidase deficiency identified by newborn screening , 2016, Genetics in Medicine.

[2]  F. Sedel,et al.  Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis , 2016, Neuropharmacology.

[3]  M. Clanet,et al.  MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study , 2016, Multiple sclerosis.

[4]  B. Wolf.  Biotinidase deficiency should be considered in individuals exhibiting myelopathy with or without and vision loss. , 2015, Molecular genetics and metabolism.

[5]  K. Pindolia,et al.  Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood , 2015, Multiple sclerosis.

[6]  D. Galanaud,et al.  High doses of biotin in chronic progressive multiple sclerosis: a pilot study. , 2015, Multiple sclerosis and related disorders.

[7]  B. Wolf.  Biotinidase deficiency: “if you have to have an inherited metabolic disease, this is the one to have” , 2012, Genetics in Medicine.

[8]  B. Wolf.  The neurology of biotinidase deficiency. , 2011, Molecular Genetics and Metabolism.

[9]  B. Wolf.  Worldwide survey of neonatal screening for biotinidase deficiency , 1991, Journal of Inherited Metabolic Disease.

[10]  T. Suormala,et al.  Delayed-onset profound biotinidase deficiency. , 1998, The Journal of pediatrics.

[11]  S. Rahman,et al.  Late presentation of biotinidase deficiency with acute visual loss and gait disturbance , 1997, Developmental medicine and child neurology.

[12]  B. Wolf,et al.  Ophthalmologic findings in biotinidase deficiency. , 1993, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[13]  W. Nance,et al.  Neonatal screening for biotinidase deficiency: results of a 1-year pilot study. , 1986, The Journal of pediatrics.

[14]  B. Wolf,et al.  Biotinidase deficiency: Initial clinical features and rapid diagnosis , 1985, Annals of neurology.

[15]  B. Wolf,et al.  Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. , 1983, Clinica chimica acta; international journal of clinical chemistry.